Literature DB >> 20097568

Standardization of radium-223 by liquid scintillation counting.

J T Cessna1, B E Zimmerman.   

Abstract

Liquid scintillation (LS) counting was undertaken as part of the primary standardization of (223)Ra. Radium-223 decays with a half life of 11.43 d through a chain of shorter-lived daughter radionuclides, resulting in five alpha decays and three beta decays. The CIEMAT/NIST method of tritium efficiency tracing was employed, with the beta efficiencies being calculated using the program CN2004, developed by the Physikalisch-Technische Bundesanstalt (PTB). The total calculated LS efficiency, considering all daughter radionuclides, was approximately 598%. Separate experiments were performed to rule out loss of the 3.96 s (219)Ra daughter from the cocktail and possible counting loss of the 1.78 ms (215)Po daughter due to LS counter dead-time. No loss was observed in either experiment. In the final experiment an expanded uncertainty (k=2) of 0.55% was achieved. Results were in excellent agreement with confirmatory measurements performed by 2pialpha proportional counting. However, results are not in agreement with methods based on gamma ray measurements. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20097568     DOI: 10.1016/j.apradiso.2009.11.068

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  2 in total

1.  Revision of the NIST Standard for (223)Ra: New Measurements and Review of 2008 Data.

Authors:  B E Zimmerman; D E Bergeron; J T Cessna; R Fitzgerald; L Pibida
Journal:  J Res Natl Inst Stand Technol       Date:  2015-03-11

2.  A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS).

Authors:  Hamza Hasan; Matthew P Deek; Ryan Phillips; Robert F Hobbs; Reem Malek; Noura Radwan; Ana P Kiess; Shirl Dipasquale; James Huang; Terry Caldwell; Jessica Leitzel; Danielle Wendler; Hao Wang; Elizabeth Thompson; Jonathan Powell; Sara Dudley; Curtiland Deville; Stephen C Greco; Daniel Y Song; Theodore L DeWeese; Michael A Gorin; Steven P Rowe; Sam Denmeade; Mark Markowski; Emmanuel S Antonarakis; Michael A Carducci; Mario A Eisenberger; Martin G Pomper; Kenneth J Pienta; Channing J Paller; Phuoc T Tran
Journal:  BMC Cancer       Date:  2020-06-01       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.